Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

43.07
-0.9400-2.14%
Post-market: 43.110.0400+0.09%19:59 EDT
Volume:11.03M
Turnover:474.48M
Market Cap:192.31B
PE:10.76
High:43.50
Open:43.20
Low:42.72
Close:44.01
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.35
T/O Rate:0.35%
Dividend:1.72
Dividend Rate:4.00%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.91
PE(LYR):11.90

Loading ...

Movement Alert|Novo-Nordisk A/S Rises 3.01% in Regular Trading, Escalates Legal Battle Seeking Injunction to Block Lilly Weight-Loss Drug Ads

Market Focus
·
Jul 28

Wall Street Analysts Are Neutral on Top Healthcare Picks

TIPRANKS
·
Jul 28

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

US Companies Face Rise in Cyber Attacks

Reuters
·
Jul 27

Dow Jones Top Company Headlines at 9 PM ET: Nvidia in Talks with Openai to Guarantee $250 Billion Financing for Data Center | Waymo ...

Dow Jones
·
Jul 27

Sector Update: Healthcare

MT Newswires Live
·
Jul 25

Novo Nordisk A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
Jul 25

Novo Nordisk Pursues Injunction to Block Eli Lilly’s (LLY) Advertisements

TIPRANKS
·
Jul 24

As Lilly and Novo Clash in Court, Wall Street is Eyeing This Bigger Prize

Dow Jones
·
Jul 24

Dow Jones Top Company Headlines at 7 am ET: Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute over Weight-loss Ads | EU ...

Dow Jones
·
Jul 24

Novo Nordisk Seeks Preliminary Injunction Against Lilly Weight-loss Ads

Reuters
·
Jul 24

Novo Nordisk: Asked the Court to Preliminarily Halt Eli Lilly's Misleading Glp-1 Advertising Campaigns While Novo Nordisk’s Lawsuit Proceeds

THOMSON REUTERS
·
Jul 24

Novo Nordisk: Filed a Motion for a Preliminary Injunction in the United States District Court for the District of New Jersey

THOMSON REUTERS
·
Jul 24

Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jul 23

PRESS Digest-british Business - July 22

Reuters
·
Jul 22

PRESS Digest-financial Times - July 22

Reuters
·
Jul 22

Trump Announces Two-Year Zero Tariffs On Imported Generics From Aug. 1, 2026; Then 100% And 200% Hikes

MT Newswires Live
·
Jul 22

Moderately bullish activity in Novo Nordisk with shares down 0.51%

TIPRANKS
·
Jul 22

Sector Update: Healthcare

MT Newswires Live
·
Jul 22

Novo Nordisk’s AMAZE 13 Trial Adds Fresh Momentum to Its Obesity Pipeline

TIPRANKS
·
Jul 22